Medically Refractory Lymphocytic Colitis Successfully... : ACG Case Reports Journal
carce evidence. Upadacitinib is a novel Janus kinase 1 selective inhibitor approved by the US Food and Drug Administration for atopic dermatitis, rheumatoid arthritis, psoriatic arthritis, ankylosing...
journals.lww.com